Powering a healthcare data company with strategic planning

We're partnering with IMO Health to develop growth strategies and build out the organization to scale.

The Opportunity

IMO Health (IMO) is a healthcare data enablement company and market leader in clinical terminology software. Its technology enables doctors and nurses to input diagnoses into electronic health records systems using their own medical lexicon, without needing to manually map that terminology against thousands of codes specific to major healthcare reimbursement systems. As a result, IMO’s software helps hospitals, healthcare systems and physician practices reduce costs and improve billing accuracy. With mission-critical technology enabling providers to deliver better care, IMO had an opportunity at the start of our partnership to accelerate its growth.

The Challenge

IMO’s core platform already fulfilled a critical need for providers by enhancing clinician operational efficiency while improving the accuracy of medical records and billing & coding.  However, the company wanted to expand its reach into new markets via innovative product offerings and strategic M&A.

The Results

Our partnership with IMO focuses on achieving scale through new product capabilities, organic growth initiatives, M&A and investments in its go-to-market function.

Expansion planning

Together with company management, we completed long-term strategic planning by developing a prioritization framework for product development and implementing an M&A strategy.

A robust sales team

We helped conduct key personnel searches to execute against our Value Creation Plan, including a buildout of the sales organization.

Related content

YA Group Announces a Majority Investment from THL Partners
Press Release
YA Group Announces a Majority Investment from THL Partners 

Partnership will support continued investments to drive organic growth and strategic acquisitions Nashville, TN, August TK, 2024/ YA GROUP (“YA,” or “the Company”), an international professional services organization providing forensic consulting, engineering, risk mitigation, and related services, today announced that it will receive a majority investment from THL Partners (“THL”), a premier private equity firm investing in
Thomas H. Lee Partners Closes $5.6 Billion Flagship Private Equity Fund
Press Release
Thomas H. Lee Partners Closes $5.6 Billion Flagship Private Equity Fund 

Fund IX focused on high-quality middle-market growth companies across Financial Services, Healthcare, and Technology & Business Solutions Strong 12 months for THL, including successful closes of the firm’s ninth flagship fund and inaugural Automation Fund, and commitments to 10 new investments BOSTON, MA – October 4, 2021 – Thomas H. Lee Partners, L.P. (“THL”), a premier private equity firm investing in middle-market growth companies, today announced the

For a list of all portfolio company investments made by THL since its inception, please click here.

Want to know more?

Learn more about our integrated approach to private equity

How we invest